← Open Payments lookup

LISA MCBRYAR: Open Payments

NPI 1205954021 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,518 in 128 payments from 16 companies in 2025. Trend: 2023 $2,245 · 2024 $1,999 · 2025 $2,518

Food & beverage: $2,518
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc13$418
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$371
Axsome Therapeutics, Inc.9$236
Otsuka America Pharmaceutical, Inc.10$218
Alkermes, Inc.11$211
Vanda Pharmaceuticals Inc.11$199
ABBVIE INC.18$194
Lundbeck LLC6$155
Noven Therapeutics, LLC6$132
Corium, LLC7$114

Products named: CAPLYTA, INVEGA SUSTENNA, REXULTI, Auvelity, VRAYLAR, LYBALVI, HETLIOZ, Xelstrym.

Industry payments across GA — which companies pay providers there.